CalciMedica, Inc. has 19 Schedule 13D or 13G filings on record since 2025-08-05. 7 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Alafi Capital Company LLC | 19.9% | 7,220,101 | SCHEDULE 13D/A, 2026-08-24 | 2026-08-19 |
| Bering Partners II GP, L.L.C. | 9.99% | 3,553,398 | SCHEDULE 13D/A, 2026-08-21 | 2026-08-19 |
| Armistice Capital, LLC | 9.99% | 3,411,361 | SCHEDULE 13G, 2026-08-14 | 2026-06-30 |
| Woodline Partners LP | 8.1% | 2,489,729 | SCHEDULE 13G, 2026-08-14 | 2026-06-30 |
| Valence Investments SPV VI, LLC | 6.4% | 316,109 | SCHEDULE 13D/A, 2026-06-30 | 2026-06-25 |
| Stonepine Capital Management, LLC | 6% | 2,149,522 | SCHEDULE 13G, 2026-08-25 | 2026-08-19 |
| CVI Investments, Inc. | 5.1% | 1,556,081 | SCHEDULE 13G, 2026-07-20 | 2026-06-23 |
| Avenue Venture Opportunities Fund II, L.P. | 4.99% | 4,641,163 | SCHEDULE 13G/A, 2026-06-25 | 2026-06-23 |
| Deerfield Mgmt, L.P. | 4.34% | 653,253 | SCHEDULE 13G/A, 2026-02-06 | 2026-02-06 |
| Soleus Capital Management, L.P. | 2.4% | 391,952 | SCHEDULE 13G/A, 2026-05-08 | 2026-03-31 |
| Chernett Jorey | 0% | 0 | SCHEDULE 13G/A, 2026-05-20 | 2026-03-31 |
Purpose of Transaction (Item 4)
Alafi Capital Company LLC
NoneItem 4 of the SCHEDULE 13D/A filed 2026-08-24
Bering Partners II GP, L.L.C.
The information set forth in Item 4 of the Original Schedule 13D is incorporated herein by reference.Item 4 of the SCHEDULE 13D/A filed 2026-08-21
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-05 | Alafi Capital Company, LLC | 11.3% | SCHEDULE 13G/A |
| 2025-09-02 | Avenue Venture Opportunities Fund II, L.P. | 8.87% | SCHEDULE 13G/A |
| 2025-09-09 | Avenue Venture Opportunities Fund II, L.P. | 8.87% | SCHEDULE 13G/A |
| 2025-10-29 | Bering Partners II, L.P. ("Bering II") | 5.8% | SCHEDULE 13G |
| 2025-11-07 | Soleus Capital Management, L.P. | 7.5% | SCHEDULE 13G/A |
| 2025-12-01 | Chernett Jorey | 7.9% | SCHEDULE 13G |
| 2026-02-06 | Deerfield Mgmt, L.P. | 4.34% | SCHEDULE 13G/A |
| 2026-05-08 | Soleus Capital Management, L.P. | 2.4% | SCHEDULE 13G/A |
| 2026-05-20 | Chernett Jorey | 0% | SCHEDULE 13G/A |
| 2026-06-25 | Avenue Venture Opportunities Fund II, L.P. | 4.99% | SCHEDULE 13G/A |
| 2026-06-30 | Valence Investments SPV VI, LLC | 6.4% | SCHEDULE 13D/A |
| 2026-07-02 | Bering Partners II GP, L.L.C. | 6.9% | SCHEDULE 13D |
| 2026-07-10 | Alafi Capital Company LLC | 17.1% | SCHEDULE 13D |
| 2026-07-20 | CVI Investments, Inc. | 5.1% | SCHEDULE 13G |
| 2026-08-14 | Woodline Partners LP | 8.1% | SCHEDULE 13G |
| 2026-08-14 | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-08-21 | Bering Partners II GP, L.L.C. | 9.99% | SCHEDULE 13D/A |
| 2026-08-24 | Alafi Capital Company LLC | 19.9% | SCHEDULE 13D/A |
| 2026-08-25 | Stonepine Capital Management, LLC | 6% | SCHEDULE 13G |
Tools for this story
Each opens in a new tab, filled in for CalciMedica, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.